NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

... it’s looking like NWBO is creating a true class of long term GBM survivors by treating them with DCVax-l, whereas in the past, most long term survivors getting SOC therapy were, by today’s standards, not suffering from GBM, but were instead exhibiting idh mutations — which are no longer considered GBM by the World Health Organization.

Agree with your statement that NWBO is creating a true class of long term GBM survivors. Do you have a good reference on the WHO reclassification of brain tumor types based on idh mutations? TIA.